Steven Leach named director at Dartmouth Norris Cotton Cancer Center

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

Steven Leach was named director of the Norris Cotton Cancer Center. He will begin his role in September.

Leach will oversee a program that combines cancer research at Dartmouth and the Geisel School of Medicine with cancer care provided across the Dartmouth-Hitchcock health system.
Leach is the David M. Rubenstein Chair and director of the Rubenstein Center for Pancreatic Cancer Research at Memorial Sloan Kettering Cancer Center.

Leach has spent the past 25 years conducting both basic science and clinical research, becoming the inaugural director of MSK’s pancreatic cancer research center in 2014. He is also a professor of surgery at Weill Medical College of Cornell University.

He previously served as the Paul K. Neumann Professor in Pancreatic Cancer Research, professor of surgery, oncology and cell biology, chief of the Division of Surgical Oncology and vice chair for academic affairs at Johns Hopkins University.

In addition to his appointment as the director of the NCCC, Leach will hold the Preston T. and Virginia R. Kelsey Distinguished Chair in Cancer at the Geisel School of Medicine at Dartmouth. This chair supports the director of the NCCC in advancing innovative research that translates into clinical and preventative cancer care.

Leach will continue his research into pancreatic cancer biology. His lab at MSK has made discoveries that have established previously unrecognized links between pancreatic development and pancreatic cancer.

More recently, Leach’s team has completed highly translational studies focused on more advanced stages of the disease, including the development of novel models for testing the drug sensitivity of each patient’s individual tumor.

YOU MAY BE INTERESTED IN

The nagging pain in Mia Sandino’s right knee set in in September 2018, and throughout her freshman year at the University of Washington, she tried to ignore it. “I was being a very naive and invincible-feeling 19-year-old,” Sandino told The Cancer Letter. “I didn’t put two and two together that this area of the knee that...

Rick Pazdur, MD, the newly appointed director for the Center for Drug Evaluation and Research at the FDA, has been described as “greyhound thin” as a result of his dedication to cycling and lifting weights in the gym each day and, for a long time, a vegetarian diet. I first met him when he was the director of the Office of Oncology Drug Products (ODP) within CDER, in 2009.
When it comes to fighting cancer today, collaboration is key. At a time when funding is uncertain, yet innovative breakthroughs are accelerating every day, it’s more important than ever for oncologists, scientists, academic researchers, and community physicians, to come together to share knowledge and gain insights about the forefront of cancer research.

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login